Stock Events

Stock Events

Inhibikase Therapeutics (IKT) Q4 2024 Earnings

14NovConfirmed

Q4 2023

Q2 2024

Q3 2024

Q4 2024

-0.85

-0.73

-0.6

-0.48

Details

Expected EPS

-0.48

Actual EPS

-0.65

Surprise EPS

-0.17

Surprise Percent

+35.42%

Description

Inhibikase Therapeutics (IKT) has reported earnings of -0.65 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.